Inventera Inc. (KOSDAQ:0007J0)

Market Cap	123.65B
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	7.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	67,073
Average Volume	322,908
Open	15,400
Previous Close	15,200
Day's Range	15,400 - 16,190
52-Week Range	15,160 - 60,200
Beta	n/a
RSI	22.97
Earnings Date	n/a

About Inventera

Inventera Inc. operates as a biotechnology company specializing in the development of MRI contrast agents. The company offers nanoparticle-based platforms, designed to enhance both the resolution and safety of MRI. The company develops contrast agents targeting the articular system, lymphatic vessels, and the pancreatic and biliary systems. Inventera Inc. was incorporated in 2018 and is based in Seoul, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2018
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 0007J0